Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review.
about
Community-acquired pneumonia: identification and evaluation of nonrespondersMechanisms of infective endocarditis: pathogen-host interaction and risk states.Biomarker-guided antibiotic therapy-strengths and limitationsA week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia.The innate immune response in HIV/AIDS septic shock patients: a comparative study.Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies.Pseudomonas aeruginosa treatment and transmission reduction.Management of severe sepsis: advances, challenges, and current status.Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.The value of C-reactive protein in infection diagnosis and prognosis in elderly patients.Personalized treatment of severe pneumonia in cancer patients.Mass spectrometry for the discovery of biomarkers of sepsis.Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers.Tumor necrosis factor receptor 1 (TNFRI) for ventilator-associated pneumonia diagnosis by cytokine multiplex analysisDiagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).Antibiotic prescription for respiratory tract infections in ventilated patients: where are we heading?Procalcitonin for antibiotic treatment in intensive care unit patients.Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock.
P2860
Q27002420-8FAFCF76-C94E-41E0-92A5-8444B74B33A8Q30317657-4FB8E59A-FF03-4937-85C8-17308F6B82F8Q33747590-F196A587-7276-4855-B007-6905A3BEFF6EQ33753745-F0BF5ED8-FA9C-4905-88D9-03ED06E8CCD9Q34850755-D1980118-D32C-4EC4-A3B3-B3A10A5E90AAQ36517624-31BE7970-FAD1-4936-B8C0-79F173AE57C2Q38095145-D1136A21-5EF4-47A0-AB06-7D523655FAACQ38131538-3B4DCB6B-33B3-4A2B-9E99-C261489D3985Q38450665-5C81F6D8-AD9B-4206-B688-A3E588DA4D90Q38550893-5CC45226-A47A-4EF9-A9FF-A89A57F61D35Q38600968-EC64A34A-DAF2-4613-868F-BFA09E9222E1Q38613281-066CE977-79F6-4440-A4DF-2C28B8D28413Q39139022-AB9645D8-DBD2-4D20-8A8B-041F83FCD573Q39158526-8DAE157F-3665-4A56-90E5-773FE8E6ED77Q40996109-0A10593F-FDFC-493C-9B80-33D09E881CA6Q41099789-F8895C45-8B22-4303-A912-1C910351D997Q45817988-660FB69E-2A1C-4AF7-A662-068E57E70741Q46478127-A22B4202-5607-424C-93D5-54A346CFAFBEQ55256161-6F41D50E-E6CA-4E0B-8090-2885BCA05F7F
P2860
Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review.
@en
type
label
Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review.
@en
prefLabel
Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review.
@en
P2860
P356
P1476
Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review.
@en
P2093
Jorge I F Salluh
Pedro Póvoa
P2860
P2888
P356
10.1186/2110-5820-2-32
P577
2012-07-23T00:00:00Z
P5875
P6179
1051718873